ME1 and obesity due to melanocortin 4 receptor deficiency: With the many tie-ins of ME1 with pathophysiology, the search for small molecule inhibitors of ME1 [69,70] with tissue-selectivity and actions may, in due course, yield useful and multipurpose drugs to treat obesity and associated co-morbidities.